ReShape Lifesciences Inc.

0.39
-0.05 (-11.46%)
At close: Mar 28, 2025, 3:59 PM
0.39
1.81%
After-hours: Mar 28, 2025, 06:57 PM EDT

ReShape Lifesciences Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
PE Ratio -0.13 -0.06 -0.29 -0.81 -0.36 -0.49 -3.27 -1.6 -9.83 n/a n/a -758.37 -522.84 -218.41 -70.11 -200.03 -38.5 -13.16 -15.61 -18.47 -37.64
PEG Ratio 0.00 0.00 0.00 0.01 0.01 -0.00 0.05 -0.01 n/a n/a n/a 24.43 8.98 3.22 -0.38 2.48 0.59 -0.71 -0.85 -0.18 n/a
PS Ratio 0.17 0.25 1.32 1.56 1.78 64.95 85.84 47.50 858.00 n/a n/a 57.02K n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 0.22 0.78 0.39 1.21 1.11 1.24 1.45 12.71 68.21 n/a n/a 1.5K 678.23 127.54 401.08 664.26 24.30 8.15 88.68 n/a -106.79
P/FCF Ratio -0.09 -0.13 -1.14 -1.97 -1.89 -1.43 -4.47 -1.81 -11.06 n/a n/a -788.77 -673.3 -277.22 -90.1 -223.4 -45.52 -13.81 -16.32 n/a n/a
P/OCF Ratio -0.09 -0.13 -1.17 -2.06 -1.89 -1.43 -4.49 -1.81 -11.08 n/a n/a -791.45 -681.82 -277.27 -90.78 -225.02 -47.08 -14.35 -17.04 n/a n/a
OCF/S Ratio -1.95 -1.95 -1.13 -0.76 -0.94 -45.31 -19.1 -26.26 -77.42 n/a n/a -72.05 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.04 0.05 0.01 0.03 0.03 0.20 0.01 0.05 0.34 0.45 0.47 0.82 0.26 0.20 1.39 1.20 0.25 0.15 4.22 n/a n/a
Quick Ratio 1.74 0.84 3.72 0.58 0.85 0.92 10.22 3.00 1.97 3.57 187.88 3.07 3.19 6.27 860.16 4.56 7.42 6.94 4.85 n/a n/a
Current Ratio 2.73 1.32 4.13 0.77 0.97 1.04 12.81 4.36 2.34 3.86 196.76 3.24 3.30 6.27 444.18 4.56 7.42 6.94 4.85 n/a n/a
Asset Turnover 0.81 1.01 0.25 0.30 0.38 0.01 0.01 0.11 0.03 n/a n/a 0.01 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -239.63 -33.35 -6.08 -35.23 -3.11K -8.11K -5.55 -29.67 -48.27 -26.53 -25 -34.94 -12.86 -5.9 -13.52 -17 -25.52 -61.56 n/a n/a
Return on Equity (ROE) -1.71 -12.62 -1.34 -1.49 -3.08 -2.56 -0.44 -7.95 -6.94 -3.92 -1.76 -1.98 -1.3 -0.58 -5.72 -3.32 -0.63 -0.62 -5.68 n/a 2.84
Return on Assets (ROA) -1.07 -4.15 -1.14 -0.58 -1.87 -1.75 -0.38 -3.32 -2.2 -1.82 -0.98 -0.9 -0.8 -0.45 -1.97 -1.34 -0.48 -0.49 -0.97 n/a -2.65
Return on Capital (ROIC) -2.13 -7.4 -0.59 -0.49 -0.54 -1.02 -0.36 -3.98 -3.92 -2.32 -0.94 -1.22 -1.1 -0.5 -1.5 -1.62 -0.55 -0.58 -1.2 n/a -2.65
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 63.93% 60.52% 61.38% 55.42% 61.67% 72.92% 27.25% 45.15% 57.19% n/a n/a 25.64% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin -131.22% -411.16% -455.39% -191.43% -491.8% -13.38K% -2.63K% -2.97K% -8.73K% n/a n/a -7.52K% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -130.62% -414.54% -456.17% -193.03% -497.71% -6.38K% -2.81K% -2.97K% -8.73K% n/a n/a -7.52K% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin -168.69% -240.91% -204.04% -110.25% -105.29% -6.35K% -2.44K% -2.9K% -9.54K% n/a n/a -7.23K% n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin -195.93% -196.02% -115.64% -79.12% -94.2% -4.54K% -1.92K% -2.63K% -7.76K% n/a n/a -7.23K% n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin -166.92% -221.75% -445.71% -160.15% -114.15% -6.09K% -2.67K% -2.48K% -9.48K% n/a n/a -7.15K% n/a n/a n/a n/a n/a n/a n/a n/a n/a